Spain Diabetes Market Report 2024-2032: A $1.32 Billion Industry Opportunity with Insights on Prevalence Trends, Demographical Breakup, Diagnosis and Treatment
October 17, 2024 04:12 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Spain Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The Spain diabetes market size reached US$ 947.9...
China Diabetes Market Report 2024-2032: China Currently has the Highest Number of Diabetics in the World
July 22, 2024 04:22 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The China diabetes market size reached US$ 4.7...
Global Antidiabetics Market Report 2024 - A $313.9 Billion Market by 2034, with CAGR of 10.9% During 2024-2034
March 18, 2024 05:10 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region" report has been added to ...
Cardiometabolic Drugs Market revenue to exceed USD 72 Billion by 2035, says Research Nester
August 21, 2023 06:00 ET
|
Research Nester
New York, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The global Cardiometabolic Drugs Market size is projected to expand at ~ 6% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...
Antidiabetics Market is estimated to reach US$ 223 Billion, displaying a CAGR of 9.6% during the assessment period from 2022 - 2032 | Future Market Insights, Inc.
June 01, 2022 11:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, June 01, 2022 (GLOBE NEWSWIRE) -- The global antidiabetics market is estimated to secure US$ 223 Billion while expanding at a CAGR of 9.6% during the forecast period. The growth of the...
Global Antidiabetics Market to Reach up to $148.3 Billion by 2027 and Witness Boosting Growth during the COVID-19 Crisis – Exclusive Report [150 Pages] By Research Dive
December 02, 2021 09:00 ET
|
Research Dive
New York, USA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global antidiabetics market explains the impact of COVID-19 pandemic on the present outlook and...
Global Antidiabetic Drug Markets Report 2021: A-Glucosidase Inhibitors, Biguanides, DPP-IV Inhibitors, Meglitinides, Sulfonylureas, Thiazolidinediones - Forecast to 2026
August 25, 2021 09:23 ET
|
Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of Covid-19 with...
China Recombinant Lispro Insulin Markets, 2016-2020 & 2021-2025
April 23, 2021 06:53 ET
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. By the end...
Diabetic Nephropathy Disease Analysis Report 2021: Overall Likelihood of Approval of a Phase I DN Asset is 4%, and the Average Probability a Drug Advances from Phase III is 33.3%
March 23, 2021 08:13 ET
|
Research and Markets
Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering. Diabetic nephropathy, also known as diabetic...
Global Type 2 Diabetes Market Outlook to 2029 - The US Market Will Contribute the Most with $57B in Sales by 2029 (62% of the Global Industry)
January 20, 2021 04:03 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering.Based on epidemiological...